Hyperfine (NASDAQ:HYPR) reported second-quarter financial results on Thursday. The transcript from the company's second-quarter earnings call has been provided below. This content is powered by Benzinga APIs. For
Hyperfine, Inc. (NASDAQ:HYPR) has reported preliminary third-quarter 2026 revenue of approximately $6.
Detailed price information for Hyperfine Inc (HYPR-Q) from The Globe and Mail including charting and trades.
GUILFORD, Conn., September 28, 2026--Hyperfine appoints Roots Pharmaceutical as exclusive Swoop system distributor in the United Arab Emirates and Kuwait.
MENLO PARK, Calif., September 16, 2026--MedtechWOMEN today announced that Maria Sainz, President and CEO of Hyperfine, Inc., has been named the recipient of its 2026 Ferolyn Powell Leadership Award, and that Beverly Tang, co-founder and CEO of Starlight Cardiovascular, has received MedtechWOMEN’s first-ever Rising Star Award. Both leaders were recognized at the annual MedtechVISION Annual Conference at the Rosewood Sand Hill in Menlo Park, Calif.
GUILFORD, Conn., September 15, 2026--Completion of enrollment in study to support anticipated indication expansion for use of the Swoop® system with contrast agents.
GUILFORD, Conn., August 31, 2026--Hyperfine, Inc. (Nasdaq: HYPR), the groundbreaking health technology company that has redefined brain imaging with the first FDA-cleared AI-powered portable MRI system for the brain—the Swoop® system—today announced plans to participate in the upcoming Lake Street Capital Markets 10th Annual Best Ideas Growth Conference on Thursday, September 10th.
GUILFORD, Conn., August 26, 2026--Peer-reviewed NEURO PMR results and 3,000+ office brain MRI scans support growing use of the Swoop system across neurology practices.
This is the newest page. Registered accounts read further back.